Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hanna K. de Jong"'
Autor:
Hanna K. de Jong, Sabine M. Hermans, Sophie M. Schuitenmaker, Maya Oli, Mariëtte A. van den Hoven, Martin P. Grobusch
Publikováno v:
The Lancet Regional Health. Europe, Vol 43, Iss , Pp 100983- (2024)
Summary: Background: Clinical trials feature centrally in the development of drugs and vaccines to determine safety and efficacy. Clinical development can be slow and may have a duration of more than ten years. Global public health threats such as Eb
Externí odkaz:
https://doaj.org/article/2583753a7a8b4dfea4b45a416dbc7507
Autor:
Hanna K. de Jong, Martin P. Grobusch
Publikováno v:
Tropical Diseases, Travel Medicine and Vaccines, Vol 10, Iss 1, Pp 1-18 (2024)
Abstract For decades, immunoglobulin preparations have been used to prevent or treat infectious diseases. Since only a few years, monoclonal antibody applications (mAbs) are taking flight and are increasingly dominating this field. In 2014, only two
Externí odkaz:
https://doaj.org/article/71a6eef9903543719662831106bfdeb1
Autor:
Anniek Strijdhorst, L. Charlotte J. de Bree, Reinout van Crevel, Hanna K. de Jong, Sabine M. Hermans
Publikováno v:
Clinical Infection in Practice, Vol 22, Iss , Pp 100354- (2024)
We describe the case of a 70-year-old immunocompromised patient who developed a severe disseminated Mycobacterium bovis BCG infection with several infected prosthetic joints and soft tissue abscesses following intravesical BCG instillation for bladde
Externí odkaz:
https://doaj.org/article/6dc10a3dcdfc42638af3a3f47b6fbeca
Autor:
Jenny L. Schnyder, Federico Gobbi, Mirjam Schunk, Andreas Lindner, Fernando Salvador, Alexandre Duvignaud, Marta Arsuaga Vicente, Jean Claude Dejon Agobé, Paolo Cattaneo, Giulia Bertoli, Camilla Rothe, Mia Wintel, Diana Pou, Denis Malvy, Ayola Akim Adegnika, Hanna K. De Jong, Martin P. Grobusch
Publikováno v:
New Microbes and New Infections, Vol 53, Iss , Pp 101136- (2023)
Background: Earlier studies found characteristic haematological changes in African patients with active schistosomiasis. If consistently present, full blood counts (FBC) may be helpful to diagnose schistosomiasis also in migrants and returning travel
Externí odkaz:
https://doaj.org/article/36f75a9cd0404ce494b11f96ba07edb9
Autor:
Manu P. Bilsen, Krista E. van Meijgaarden, Hanna K. de Jong, Simone A. Joosten, Corine Prins, Lucia J.M. Kroft, Jacqueline T. Jonker, Stijn Crobach, Rob C. Pelger, Tom H.M. Ottenhoff, Sandra M. Arend
Publikováno v:
International Journal of Infectious Diseases, Vol 72, Iss , Pp 63-68 (2018)
Intravesical bacillus Calmette-Guérin (BCG) is widely used for high-risk, non-muscle-invasive bladder cancer. This report describes four cases that illustrate the spectrum of BCG-induced complications, varying from granulomatous prostatitis to sepsi
Externí odkaz:
https://doaj.org/article/8c1d9c161de041498512d2d766ad2ef1
Autor:
Jenny L. Schnyder, Hanna K. de Jong, Emmanuel B. Bache, Reinier M. van Hest, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch
Publikováno v:
Travel medicine and infectious disease, 52:102520. Elsevier USA
According to current guidelines, atovaquone-proguanil (AP) malaria chemoprophylaxis should be taken once daily starting one day before travel and continued for seven days post-exposure. However, drug-sparing regimens, including discontinuing AP after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::295ba4f5f2e0e7a18d8e735e2aa51d9e
https://pure.amc.nl/en/publications/on-the-potential-for-discontinuing-atovaquoneproguanil-ap-adhoc-postexposure-and-other-abbreviated-apregimens(8cc2ac8f-ee7d-419a-9950-fd1575ef22b0).html
https://pure.amc.nl/en/publications/on-the-potential-for-discontinuing-atovaquoneproguanil-ap-adhoc-postexposure-and-other-abbreviated-apregimens(8cc2ac8f-ee7d-419a-9950-fd1575ef22b0).html
Autor:
Eva L. Koekenbier, Konstantin Fohse, Josephine S. van de Maat, Jan Jelrik Oosterheert, Cees van Nieuwkoop, Jacobien J. Hoogerwerf, Martin P. Grobusch, Maurice A.A.J. van den Bosch, Janneke H.H. van de Wijgert, Mihai G. Netea, Frits R. Rosendaal, Marc J.M. Bonten, C.H. (Henri) van Werkhoven, Astrid Aardenburg-van Huisstede, Heidi S.M. Ammerlaan, Willem G. Boersma, Kees Brinkman, Patricia C.J. Bruijning-Verhagen, Reinout van Crevel, Corine Delsing, Thijs ten Doesschaten, Anton S.M. Dofferhoff, Ruud Duijkers, Rolf H.H. Groenwold, Corine de Haas, Robert-Jan Hassing, Marieke L.A. de Hoog, Susanne M. Huijts, Astrid van Hylckama-Vlieg, Eefje Jong, Hanna K. de Jong, Martijn Knap, Michael Koenders, Ilse J.E. Kouijzer, Henk Kramer, Roel van de Laar, Arief Lalmohamed, Karel-Jan D.F. Lensen, Willem M. Lijfering, Fabienne Magdelijns, Bob Meek, Rutger A. Middelburg, Hazra S. Moeniralam, Simon P. Mooijaart, Barbara C. van Munster, Jaap ten Oever, Marc Padros Goossens, Vincent Peters, Douwe F. Postma, Niels Pouw, Herre J. Reesink, Marieke J.A. de Regt, Anneli C.J. van der Reijden, R. Schaakxs, Kitty Slieker, Robbert J. Slingerland, Nicolette L.J. van Sluis, Coen D.A. Stehouwer, Frank van de Veerdonk, Annelies Verbon
Publikováno v:
Clinical Microbiology and Infection, 29, 6, pp. 781-788
Clinical Microbiology and Infection. ELSEVIER SCI LTD
Clinical microbiology and infection. Elsevier Limited
Clinical Microbiology and Infection, 29, 781-788
Clinical Microbiology and Infection. ELSEVIER SCI LTD
Clinical microbiology and infection. Elsevier Limited
Clinical Microbiology and Infection, 29, 781-788
Contains fulltext : 293489.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To test whether Bacillus Calmette-Guérin (BCG) vaccination would reduce the incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with on
Publikováno v:
Clinical microbiology and infection, 28(1), 6-8. Elsevier Limited
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Autor:
Jenny L. Schnyder, Hanna K. de Jong, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch
Publikováno v:
Travel Medicine and Infectious Disease. 49:102365
© 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Background: Atovaquone/proguanil (AP) is a highly effective malaria chemoprophylaxis combination
Background: Atovaquone/proguanil (AP) is a highly effective malaria chemoprophylaxis combination
Autor:
Gavin C K W Koh, Tassili A Weehuizen, Katrin Breitbach, Kathrin Krause, Hanna K de Jong, Liesbeth M Kager, Arjan J Hoogendijk, Antje Bast, Sharon J Peacock, Tom van der Poll, Ivo Steinmetz, W Joost Wiersinga
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 7, Iss 10, p e2500 (2013)
Burkholderia pseudomallei infection (melioidosis) is an important cause of community-acquired Gram-negative sepsis in Northeast Thailand, where it is associated with a ~40% mortality rate despite antimicrobial chemotherapy. We showed in a previous co
Externí odkaz:
https://doaj.org/article/2882ae12f52944739cca9b84fe471122